Skip to main content
SpringerLink
Log in

The Historical Perspective of Gastric Cancer

  • Chapter
  • First Online:
Gastric Cancer

Abstract

Current discussions on a scientific issue in the area of medicine should start by casting a quick glance at the historical development of previous etiological, pathogenetic, diagnostic, and therapeutic findings.

Looking back helps to clarify whether an idea of one’s own or a colleague’s, concerning a certain scientific issue, has already been communicated and treated in a study.

Looking at the history of the therapy of an illness also serves as a frequently underestimated source for new scientific approaches and innovative curing processes. In this book Gastric Cancer: Principles and Practice-Materials and Instructions, the historical retrospect presents a cross section of different therapeutic approaches spanning the past 125 years.

During the course of this long period, grand developments in the field of gastric carcinoma can be observed. It began with the surgical therapy of gastric resection around the year 1881, followed by a systematic histological work-up, as well as diverse surgical principles of radicalness and reconstructive procedures.

Throughout past decades, competence centers were established that carried out and evaluated a wide variety of chemotherapy, radiation therapy, and specific antibody therapy.

This historical perspective of therapeutic developments mentioned is meant to promote the readers’ interest in the body of knowledge on gastric carcinoma—as well as to provide the expert with motivation and assistance for further innovations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ziegler H. Billroths first gastric resection. Der Krebsarzt. 1949;4(2):49–59. (Available only in German).

    Google Scholar 

  2. Vogel B. Therapie des Magenkarzinoms im Wandel der Zeit. Medizinische Fakultät der Westfälischen Wilhelms-Universität Münster; 2004.

    Google Scholar 

  3. Hacker von V. Zur Kasuistik und Statistik der Magenresektionen und Gastroenterostomien. Zentralbl Chir. 1885;12:60–8.

    Google Scholar 

  4. Kocher T. Zur Technik und zu den Erfolgen der Magenresektion. Zentralbl Chir. 1894;10:221–3.

    Google Scholar 

  5. Orr TG. A modified technic for total gastrectomy. Arch Surg. 1947;54(3):279–86.

    Article  CAS  PubMed  Google Scholar 

  6. Schlatter C. Über Ernährung und Verdauung nach vollständiger Entfernung des Magens—Ösophagoenterostomie—beim Menschen. Bruns Beiträge Klin Chir. 1897;19:757–76.

    Google Scholar 

  7. Ringel T. Die Resultate der operativen Behandlung des Magencarcinoms. Bruns Beiträge. 1903;38:585–600.

    Google Scholar 

  8. Mikulicz von J. Chirurgische Erfahrungen über Magencarcinom. Centralbl Chir. 1901;48:1197–201.

    Google Scholar 

  9. Finney JM, Rienhoff WF. Gastrectomy. Arch Surg. 1929;2:141–62.

    Google Scholar 

  10. Hinz R. Zur Technik der totalen Magenexstirpation. Arch klin Chir. 1924;132:635–45.

    Google Scholar 

  11. Altschul W. Beitrag zur Chirurgie des Magenkarzinoms. Bericht über 612 in der Zeit von 1895–1911 beobachtete Fälle. Bruns Beiträge. 1913;84:421–71.

    Google Scholar 

  12. Roux C. L’esophago-jejune-gastrome. Nouvelle Opération Pour Retricissement Infranchissable de L’ésophage. Semaine Med. 1907;27:37–42.

    Google Scholar 

  13. Hunt CJ. Construction of food pouch from segment of jejunum as substitute for stomach in total gastrectomy. Arch Surg. 1952;64:601–8.

    Article  CAS  Google Scholar 

  14. Longmire WP. Construction of a substitute gastric reservoir following total gastrectomy. Ann Surg. 1952;135:637–45.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Pack GT, McNeer G. Total gastrectomy for cancer. Surg Gynecol Obstet. 1943;77:265–99.

    Google Scholar 

  16. Steingräber M. Operationsmortalität und Überlebensdauer nach der Gastrektomie. Zentralbl Chir. 1954;79:1089–95.

    PubMed  Google Scholar 

  17. Häring R, Eckart J, John St, Perez P, Stallkamp B, Tung LC, Waldschmidt J. Die Nahtinsuffizienz der oesophagealen Anastomose nach Gastrektomie und Kardiaresektion. Langenbecks Arch Chir. 1971;328:295–310.

    Article  PubMed  Google Scholar 

  18. Lawrence W, McNeer G. An analysis of the role of radical surgery for gastric cancer. Surg Gyn Obstet. 1960;111:691–6.

    Google Scholar 

  19. Holle F. Über die Indikation zur partiellen und totalen Resektion des Magens bei Carcinom. Chirurg. 1960;3:103–10.

    Google Scholar 

  20. Coller FA, Kay EB, McIntyre RS. Regional lymphatic metastases of carcinoma of the stomach. Arch Surg. 1941;43:748–61.

    Article  Google Scholar 

  21. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1964;64:31–49.

    Google Scholar 

  22. Gütgemann A, Schreiber HW, Bernhard A. Erfahrungen mit der totalen Gastrektomie. Langenbecks Arch Chir. 1963;303:73–93.

    Article  Google Scholar 

  23. Longmire WP. Total gastrectomy for carcinoma of the stomach. Surg Gyn Obstet. 1947;84:21–30.

    Google Scholar 

  24. Lortat-Jacob J, Giuli R, Estenne B, Clot P. Value of total gastrectomy for treatment of cancers of the stomach. Study of 482 radical operations. Chirurgie. 1975;101:59–67.

    CAS  PubMed  Google Scholar 

  25. Coller FA, Kay EB, McIntyre RS. Regional lymphatic metastases of carcinoma of the stomach. Arch Surg. 1941;43:748–61.

    Article  Google Scholar 

  26. Bittner R. Gastrectomie de nécessité. Langenbecks Arch Chir. 1987;372:577–82.

    Article  CAS  PubMed  Google Scholar 

  27. Hermanek P. Differenziertes chirurgisches Vorgehen bei der kurativen Therapie des Magenkarzinoms. Leber Magen Darm. 1996;26:64–72.

    CAS  PubMed  Google Scholar 

  28. Hermanek P. Chirurgische Pathologie-TNM-System. Langenbecks Arch Chir. 1982;358:57–63.

    Article  CAS  PubMed  Google Scholar 

  29. Peiper HJ. Prinzipielle Gastrektomie beim Magenkarzinom—Pro und Kontra. Med Welt. 1982;33:241–5.

    CAS  PubMed  Google Scholar 

  30. Schwemmle K. Subtotale oder totale Resektion beim Magenkarzinom: Vertreter des Contra. Therapiewoche. 1980;30:8557–9.

    Google Scholar 

  31. Hamelmann H. Stadiengerechte Chirurgie: Magenresektion und Relation zur Lokalisation, dem Tumortyp und der Ausdehnung. In: Bünte H, Herausgeber. Aktuelle Therapie des Magenkarzinoms. Berlin: Springer; 1985. pp. 47–59.

    Google Scholar 

  32. Junginger T. Konsensus der CAO, AIO und ARO: Multimodale Therapie bei Magenkarzinom. Onkologie. 1995;18:488–9.

    Article  Google Scholar 

  33. Eypasch E, Wood-Dauphinée S, Williams JI, Ure B, Neugebauer E, Troidl H. Der Gastrointestinale Lebensqualitätsindex (GLQI). Chirurg. 1993;64:264–74.

    CAS  PubMed  Google Scholar 

  34. Bozzetti F, Bonfanti G, Gennari L. Subtotal gastrectomy or en principle total gastrectomy in cancer of the lower half of the stomach. Onkologie. 1992;15:84–91.

    Article  Google Scholar 

  35. Delbrück H, Severin M, Jansen G. Postgastrektomiebefunde in der Nachsorge von 227 Patienten mit Magenkarzinom. Z Gastroenterol. 1991;29:222–6.

    PubMed  Google Scholar 

  36. Buhl K, Lehnert T, Schlag P, Herfarth C. Reconstruction after gastrectomy and quality of life. World J Surg. 1995;19:558–64.

    Article  CAS  PubMed  Google Scholar 

  37. Jinnai D. Evaluation of extended radical operation for gastric cancer, with regard to lymph node metastasis and follow-up results. Gann. 1968;3:225–31.

    Google Scholar 

  38. Soga J. The role of lymphadenectomy in curative surgery for gastric cancer. World J Surg. 1979;3:701–8.

    Article  CAS  PubMed  Google Scholar 

  39. Böttcher K, Roder JD, Siewert JR. für Deutsche Magenkarzinom-Studiengruppe. Wertigkeit der radikalen Lymphknotendissektion (Compartment I und II) beim Magenkarzinom. Zentralbl Chir. 1996;121:131–8.

    PubMed  Google Scholar 

  40. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908–14.

    Article  CAS  PubMed  Google Scholar 

  41. Bengmark S, Domellöf L, Olsson AM. The role of splenectomy in stomach cancer operations. Digestion. 1971;4:314.

    Article  CAS  PubMed  Google Scholar 

  42. Brady MS, Rogatko A, Dent LL, Shiu MH. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg. 1991;126:359–64.

    Article  CAS  PubMed  Google Scholar 

  43. Aretxabala de X, Konishi K, Yonemura Y, Ueno K, Yagi M, Noguchi M, Miwa K, Miyazaki I. Node dissection in gastric cancer. Br J Surg. 1987;74:770–3.

    Article  PubMed  Google Scholar 

  44. Maehara Y, Moriguchi S, Yoshida M, Takahashi I, Korenaga D, Sugimachi K. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Cancer. 1991;67:3006–9.

    Article  CAS  PubMed  Google Scholar 

  45. Chew-Wun W, Maw-Jye H, Su-Shun L, Shyh-Haw T, Wing-Yiu L, Fang-Ku P. Lymph node metastasis from carcinoma of the distal one-third of the stomach. Cancer. 1994;73:2059–64.

    Article  Google Scholar 

  46. Koga S, Kaibara N, Kimura O, Nishidoi H, Kishimoto H. Prognostic significance of combined splenectomy of pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer. Am J Surg. 1981;142:546–50.

    Article  CAS  PubMed  Google Scholar 

  47. Brady MS, Rogatko A, Dent LL, Shiu MH. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg. 1991;126:359–64.

    Article  CAS  PubMed  Google Scholar 

  48. Meyer H-J, Jähne J, Weimann A, Pichlmayr R. Chirurgische Therapie des Magenkarzinoms—Indikationen zur Splenektomie bei der Gastrektomie. Chirurg. 1994;65:437–40.

    CAS  PubMed  Google Scholar 

  49. Böttcher K, Becker K, Busch R, Roder JD, Siewert JR. Prognosefaktoren beim Magencarcinom. Chirurg. 1992;63:656–61.

    PubMed  Google Scholar 

  50. Bozzetti F, Regalia E, Bonfanti G, Doci R, Ballarini D, Gennari L. Early and late results of extended surgery for cancer of the stomach. Br J Surg. 1990;77:53–56.

    Article  CAS  PubMed  Google Scholar 

  51. Meyer H-J, Jähne J, Wilke H. Perspectives of surgery and multimodality treatment in gastric carcinoma. J Cancer Res Clin Oncol. 1993;119:384–94.

    Article  CAS  PubMed  Google Scholar 

  52. Hirner A, Häring R, Kania U, Weber B. Maßnahmen beim Lokalrezidiv des Magenkarzinoms. In: Häring R, Herausgeber. Therapie des Magenkarzinoms. edition medizin, 1. Aufl, Germanay: Weinheim; 1984. pp. 715–22.

    Google Scholar 

  53. Dixon WJ. Use of triethylenethiophoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma. Ann Surg. 1971;173:26–39.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Serlin O, Keehn RJ, Higgins GA. Factors related to survival following resection for gastric carcinoma. Cancer. 1977;40:1318–29.

    Article  CAS  PubMed  Google Scholar 

  55. Comis CL, Carter SK. A review of chemotherapy in gastric cancer. Cancer. 1974;34:1576–86.

    Article  CAS  PubMed  Google Scholar 

  56. Alcobendas F, Milla A, Estape J, Curto J, Pera C. Mitomycin C as an adjuvant in resected gastric cancer. Ann Surg. 1983;198:13–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Kovack JS, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ. A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil for advanced gastric and pancreatic cancer. Cancer. 1974;33:563–7.

    Article  Google Scholar 

  58. Gastrointestinal Tumor Study Group. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer. 1982;49:1771–7.

    Article  Google Scholar 

  59. Engstrom PF, Lavin PT, Douglass HO, Brunner KW. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Cancer. 1985;55:1868–73.

    Article  CAS  PubMed  Google Scholar 

  60. Macdonald JS. 5-fluorouracil, adriamycin and mitomycin-C—(FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer. 1979;44:42–7.

    Article  CAS  PubMed  Google Scholar 

  61. Queißer W. Chemotherapy of advanced gastric carcinoma. Onkologie. 1986;9:319–31.

    Article  PubMed  Google Scholar 

  62. Klein HO, Dias Wickramanayake P, Dieterle F, Mohr R, Oekermann H, Brock J, Beyer D, Gross R. Chemotherapieprotokoll zur Behandlung des metastasierenden Magenkarzinoms. Dtsch Med Wschr. 1982;107:1708–12.

    Article  CAS  PubMed  Google Scholar 

  63. Leichmann L, Macdonald B, Dindogru A, Samson M. Platinum: a clinically active drug in advanced adenocarcinoma of the stomach. Proc Am Ass Cancer Res. 1982;110:430–6.

    Google Scholar 

  64. Moertel CG, Mittelman JA, Bakemeier RF, Engstrom P, Hanley J. Sequential and combination chemotherapy of advanced gastric cancer. Cancer. 1976;38:678–82.

    Article  CAS  PubMed  Google Scholar 

  65. Inberg MV, Heinonen R, Rantakokko V, Viikari SJ. Surgical treatment of gastric carcinoma. Arch Surg. 1975;110:703–7.

    Article  CAS  PubMed  Google Scholar 

  66. Preusser P. Chemotherapie des Magenkarzinoms. In: Bünte H, Meyer J, Preusser P, Herausgeber. Gastrointestinale Malignome. Interdisziplinäre Therapiekonzepte. 1. Aufl. Köln: Dtsch Ärzte-Verlag; 1990. pp. 74–93.

    Google Scholar 

  67. Haim N, Tsalik M, Robinson E. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules. Oncology. 1994;51:102–7.

    Article  CAS  PubMed  Google Scholar 

  68. Lerner A, Gonin R, Steel GD, Mayer AJ. Etoposide, doxorubicin and cisplatin chemotherapy for advanced gastric adenocarcinoma a phase II trial. J Clin Oncol. 1992;10:536–40.

    CAS  PubMed  Google Scholar 

  69. Kelsen DA, Atiq OT, Saltz L, et al. FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol. 1992;10:541–8.

    CAS  PubMed  Google Scholar 

  70. Hermans J, Bonenkamp JJ, Boon MC, Bunt AMG, Ohyama S. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol. 1993;11:1441–7.

    CAS  PubMed  Google Scholar 

  71. Siewert JR, Fink U. Multimodale Therapiekonzepte bei Tumoren des Gastrointestinaltraktes. Chirurg. 1992;63:242–50.

    CAS  PubMed  Google Scholar 

  72. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 1983;43:1488–92.

    CAS  PubMed  Google Scholar 

  73. Fisher B, Gunduz N, Coyle J. Presence of a growth stimulating factor in serum following primary tumor removal in mice. Cancer Res. 1989;49:1996–2001.

    CAS  PubMed  Google Scholar 

  74. Fink U, Schuhmacher C, Stein HJ, et al. Preoperative chemotherapy for stage III-IV gastric carcinoma, response and outcome after complete resection. Br J Surg. 1995;82:1248–52.

    Article  CAS  PubMed  Google Scholar 

  75. Villar-Grimalt A, Candel MT, Garcia J, Bernacer B, Jimeno J. Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity. Ann Oncol. 1991;2:310–1.

    CAS  PubMed  Google Scholar 

  76. Markman M. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg Gynecol Obstet. 1987;164:89–93.

    CAS  PubMed  Google Scholar 

  77. Sugarbaker PH. Management of peritoneal carcinomatosis. Acta Med Austriaca. 1989;16:57–60.

    CAS  PubMed  Google Scholar 

  78. Archer SG, Gray BN. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver metastases. Surgery. 1990;108:502–7.

    CAS  PubMed  Google Scholar 

  79. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol. 1994;12:970–4.

    CAS  PubMed  Google Scholar 

  80. Takahashi T, Hagiwara A, Shimotsuma M. Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles with advanced gastric cancer. Eur J Surg Oncol. 1994;20:183–4.

    CAS  PubMed  Google Scholar 

  81. Takahashi T, Hagiwara A, Shimotsuma M, Sawai K, Yamaguchi T. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J Surg. 1995;19:565–9.

    Article  CAS  PubMed  Google Scholar 

  82. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer. 1994;73:2048–52.

    Article  CAS  PubMed  Google Scholar 

  83. Fraass B, Miller AW, Kinsella TJ, Sindelar WF, Harrington FS, Yeakel K. Intraoperative radiation therapy at the National Cancer Institute: technical innovations and dosimetry. Int J Radiat Oncol Biol Phys. 1985;11:1299–311.

    Article  CAS  PubMed  Google Scholar 

  84. Abe M, Shibamoto Y, Takahashi M, Manabe T, Tobe T, Inamoto T. Intraoperative radiotherapy in carcinoma of the stomach and pancreas. World J Surg. 1987;11:459–64.

    Article  CAS  PubMed  Google Scholar 

  85. Abe M, Nishimura Y, Shibamoto Y. Intraoperative radiation therapy for gastric cancer. World J Surg. 1995;19:554–7.

    Article  Google Scholar 

  86. Calvo FA, Henriquez I, Santos M, Escude L, et al. Intraoperative and external beam radiotherapy in advanced resectable gastric cancer: technical description and preliminary results. Int J Radiat Oncol Biol Phys. 1989;17:183–9.

    Article  CAS  PubMed  Google Scholar 

  87. Krämling HJ, Wilkowski R, Duhmke E, Cramer C, Willich N, Schildberg FW. Adjuvante intraoperative Strahlentherapie (IORT) beim Magenkarzinom. Langenbecks Arch Chir (Suppl). 1996;113:211–3.

    Google Scholar 

  88. Abe M, Yabumoto E, Takahashi M, Tobe T, Mori K. Intraoperative radiotherapy of gastric cancer. Cancer. 1974;34:2034–41.

    Article  CAS  PubMed  Google Scholar 

  89. Noyes RD, Weiss SM, Krall JM. Surgical complications of intraoperative radiation therapy: the Radiation Therapy Oncology Group experience. J Surg Oncol. 1992;50:209–15.

    Article  CAS  PubMed  Google Scholar 

  90. Juhl H, Kalthoff H, Krüger U, Henne-Bruns D, Kremer B. Immunzytologischer Nachweis mikrometastatischer Zellen bei Patienten mit gastrointestinalen Tumoren. Zentralbl Chir. 1995;120:116–22.

    CAS  PubMed  Google Scholar 

  91. Schlimok G, Funke I, Pantel K, et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer. 1991;27:1461–5.

    Article  CAS  PubMed  Google Scholar 

  92. Schlimok G, Funke I, Holzmann B, et al. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci U S A. 1987;84:8672–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  93. Nakajima T, Harashima S, Hirata M, Kajitani T. Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol. 1978;22:225–9.

    CAS  PubMed  Google Scholar 

  94. Schott A, Vogel I, Krüger U, Kalthoff H, Schreiber H-W, Schmiegel W, Henne-Bruns D, Kremer B, Juhl H. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg. 1998;227:372–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  95. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, Yamamoto M. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg. 1990;77:436–9.

    Article  CAS  PubMed  Google Scholar 

  96. Jauch K-W, Heiss MM, Grützner U, Funke I, Pantel K, Babic R, Eissner H-J, Riethmüller G, Schildberg F-W. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol. 1996;14:1810–7.

    CAS  PubMed  Google Scholar 

  97. Strong V. Defining the role of laparoscopic gastrectomy for gastric cancer. J Clin Oncol. 2014;32(7):613–4.

    Article  PubMed  Google Scholar 

  98. Yada T, Yokoi C, Uemura N. The current state of diagnosis and treatment for early gastric cancer. vol. 2013. Cairo: Hindawi Publishing Corporation. Article ID 241320; 2013.

    Google Scholar 

  99. Billroth T. About 124 performed gastric and colon resections, gastroenterostomies and freeing of adhesions due to chronic intraabdominal diseases from November 1878 to June 1890 in my Clinic at the AKH in Vienna. Lecture at the surgical Section during the international congress in Berlin; 1890. (Available only in german).

    Google Scholar 

Download references

Acknowledgments

We want to thank Dr. med. Birte Vogel, orthopedic surgeon in Cologne for collecting data.

Author information

Authors and Affiliations

  1. SMZ-Ost, Donauspital-Wein Chirurgie, Vienna, Austria

    Prof. Michael A. Rogy

  2. Medical School, University of Vienna, Vienna, Austria

    Marius A. Bünger Cand Med

Authors
  1. Prof. Michael A. Rogy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marius A. Bünger Cand Med
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael A. Rogy .

Editor information

Editors and Affiliations

  1. Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Vivian E. Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rogy, M., Bünger, M. (2015). The Historical Perspective of Gastric Cancer. In: Strong, V. (eds) Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-15826-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15826-6_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15825-9

  • Online ISBN: 978-3-319-15826-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation